{"id":"NCT03528681","sponsor":"AstraZeneca","briefTitle":"A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.","officialTitle":"A Phase 3 Multicenter, Prospective, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of ZS (Sodium Zirconium Cyclosilicate), in Patients With Hyperkalemia-HARMONIZE Asia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-06","primaryCompletion":"2022-09-15","completion":"2022-09-15","firstPosted":"2018-05-18","resultsPosted":"2025-05-14","lastUpdate":"2025-05-14"},"enrollment":270,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperkalemia"],"interventions":[{"type":"DRUG","name":"Sodium Zirconium Cyclosilicate 5g","otherNames":[]},{"type":"DRUG","name":"Sodium Zirconium Cyclosilicate 10g","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sodium Zirconium Cyclosilicate 10g","type":"EXPERIMENTAL"},{"label":"Sodium Zirconium Cyclosilicate 5g","type":"EXPERIMENTAL"},{"label":"Matching Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of two different doses (5 and 10 g) of ZS orally administered once daily (qd) vs placebo in maintaining normokalemia in initially hyperkalemic patients having achieved normokalemia following 24 or 48 hours of initial ZS therapy (10g TID).","primaryOutcome":{"measure":"Least Square Mean S-K Level on Days 8-29","timeFrame":"Days 8 to 29 (Randomized treatment study phase) used for model-based least squares mean computation","effectByArm":[{"arm":"Sodium Zirconium Cyclosilicate (SZC) 5g QD","deltaMin":4.859,"sd":null},{"arm":"Sodium Zirconium Cyclosilicate (SZC) 10g QD","deltaMin":4.44,"sd":null},{"arm":"Placebo","deltaMin":5.225,"sd":null}],"pValues":[{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG002 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":66,"countries":["China","India"]},"refs":{"pmids":["39112102"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D9480C00001&amp;attachmentIdentifier=a47248d4-96f9-4b78-b851-24164ffe2f86&amp;fileName=D9480C00001_CSP_Redacted.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D9480C00001&amp;attachmentIdentifier=6c844f0b-5f48-44bd-9c27-e4539f412cd3&amp;fileName=D9480C00001_SAP_Redacted.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D9480C00001&amp;attachmentIdentifier=bfc960c6-5f05-4753-8c1e-c6bc683bacd6&amp;fileName=D9480C00001_CSR_Synopsis_Redacted.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":270},"commonTop":["Oedema peripheral","Constipation","Dizziness","Upper respiratory tract infection","Diarrhoea"]}}